Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF)
Clinical trial NCT03611153 · COMPLETED
Trial details
- NCT number
- NCT03611153
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2022-02-11
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.